Domino’s coding and marking printer range has been approved by pharmaceutical packaging expert Uhlmann, creating opportunities for manufacturers to integrate both companies' system solutions into their lines to meet track and trace requirements for upcoming anti-counterfeit legislation.
Uhlmann’s serialisation solution, together with Domino's printers, has been given the seal of approval by customers and technical experts as a robust and successful solution that is compliant with the EU Falsified Medicines Directive (FMD), set to be implemented by 2018.
For Uhlmann, the compatibility highlights easy integration as a key benefit of its technology. “With fewer than three years to go until anti-counterfeit legislation is enforced across Europe, manufacturers require the support of packaging and coding experts who can work together to offer integrated solutions for the pharmaceutical industry,” said Roland Laengle, manager, sales support software and automation at Uhlmann. “Our customers can be assured that Domino’s thermal inkjet and laser printing technology can be used in line with our equipment to ensure printing runs at the highest operating speeds and print quality, adhering to industry legislation.”
Domino’s thermal inkjet and laser equipment has been developed for code durability and to handle unique numbers at speed, with compatibility a key benefit for customers who will by now be implementing serialisation solutions in preparation for the EU FMD. “The industry faces a huge challenge as processes change from batch to item-level serialisation," said Craig Stobie, head — global life sciences team at Domino. “Equipment compatibility with packaging leaders such as Uhlmann shows our manufacturers that our serialisation solutions can be deployed with minimal disruption in packaging halls during installation and no long term impact on OEE for manufacturers.”